MedPath

Lupin Research Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

6

Active:0
Completed:4

Trial Phases

3 Phases

Phase 2:4
Phase 3:1
Phase 4:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (6 trials with phase data)• Click on a phase to view related trials

Phase 2
4 (66.7%)
Phase 3
1 (16.7%)
Phase 4
1 (16.7%)

A Study to Evaluate the Effect of a Contraceptive Vaginal Ring LSP- 5415 on Ovarian Function in Healthy Adult Females

Phase 2
Completed
Conditions
Pregnancy Prevention
Interventions
First Posted Date
2022-05-04
Last Posted Date
2023-03-09
Lead Sponsor
Lupin Research Inc
Target Recruit Count
26
Registration Number
NCT05360550
Locations
🇮🇳

Site 01, Mahape, Mumbai, India

An Open-label, Randomized, 2-Period, Crossover, Pharmacokinetics Study

Phase 2
Completed
Conditions
Pregnancy Prevention
Interventions
Drug: LSP-5415 (etonogestrel/ethinyl estradiol vaginal ring)
First Posted Date
2022-05-04
Last Posted Date
2022-07-19
Lead Sponsor
Lupin Research Inc
Target Recruit Count
40
Registration Number
NCT05360576
Locations
🇮🇳

Site 01, Mahape, Mumbai, India

Evaluate the Safety of a Single Oral Dose of Solosec™ (Secnidazole) 2g for the Treatment of Adolescent Girls With BV

Phase 4
Completed
Conditions
Bacterial Vaginoses
Interventions
First Posted Date
2019-05-06
Last Posted Date
2020-12-19
Lead Sponsor
Lupin Research Inc
Target Recruit Count
40
Registration Number
NCT03937869
Locations
🇺🇸

Site 1004 - Investigational Research Center, Long Beach, California, United States

🇺🇸

Site 1005 - Investigational Research Center, Hialeah, Florida, United States

🇺🇸

Site 1001 - Investigational Research Center, Miami Lakes, Florida, United States

and more 6 locations

A Phase 3 Study of Solosec® for the Treatment of Trichomoniasis

Phase 3
Completed
Conditions
Trichomonas Infection
Interventions
Drug: Placebo
First Posted Date
2019-05-02
Last Posted Date
2023-10-04
Lead Sponsor
Lupin Research Inc
Target Recruit Count
147
Registration Number
NCT03935217
Locations
🇺🇸

Site 1007, Birmingham, Alabama, United States

🇺🇸

Site 1003, North Miami, Florida, United States

🇺🇸

Site 1014, Chicago, Illinois, United States

and more 8 locations

News

No news found
© Copyright 2025. All Rights Reserved by MedPath